A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors
BeOne Medicines
BeOne Medicines
BeOne Medicines
Mayo Clinic
M.D. Anderson Cancer Center
Royal Marsden NHS Foundation Trust
GlaxoSmithKline
NYU Langone Health
Sun Yat-sen University
Shandong Cancer Hospital and Institute
Sirtex Medical
University of Kentucky
BeiGene
OHSU Knight Cancer Institute
Wake Forest University Health Sciences
University of Wisconsin, Madison
Jiangsu HengRui Medicine Co., Ltd.
Swiss Cancer Institute
Pfizer
Shanghai Junshi Bioscience Co., Ltd.
Medical College of Wisconsin
University of Maryland, Baltimore
UNICANCER
University of Maryland, Baltimore
University of Ulm
Technische Universität Dresden
St. Joseph's Hospital and Medical Center, Phoenix
Henan Cancer Hospital
Nohla Therapeutics, Inc.
UNICANCER
Pfizer
Sun Yat-sen University
Abramson Cancer Center at Penn Medicine
CTI BioPharma
Celldex Therapeutics
Concordia Laboratories Inc.
Institut Cancerologie de l'Ouest
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Northwell Health
Centre Francois Baclesse
University of Utah
H. Lee Moffitt Cancer Center and Research Institute
Georgetown University
Bristol-Myers Squibb
Aalborg University Hospital
Washington University School of Medicine
Intergroupe Francophone de Cancerologie Thoracique
Hoffmann-La Roche
University of Southern California
University of Chicago
National Cancer Institute (NCI)